Topp, M. S., Gökbuget, N., Zugmaier, G., Degenhard, E., Goebeler, M., Klinger, M., . . . Bargou, R. C. (2012). Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL.
芝加哥风格引文Topp, Max S., et al. Long-term Follow-up of Hematologic Relapse-free Survival in a Phase 2 Study of Blinatumomab in Patients with MRD in B-lineage ALL. 2012.
MLA引文Topp, Max S., et al. Long-term Follow-up of Hematologic Relapse-free Survival in a Phase 2 Study of Blinatumomab in Patients with MRD in B-lineage ALL. 2012.
警告：这些引文格式不一定是100％准确.